UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Parkin Precipitates on Mitochondria via Aggregation and Autoubiquitination

International journal of molecular sciences, 2023-05, Vol.24 (10), p.9027

2023

Volltextzugriff (PDF)

History of Parkinson's Disease-Associated Gene, Parkin : Research over a Quarter Century in Quest of Finding the Physiological Substrate

International journal of molecular sciences, 2023-12, Vol.24 (23), p.16734

2023

Volltextzugriff (PDF)

Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice

Scientific reports, 2017-11, Vol.7 (1), p.16533-18, Article 16533

2017

Volltextzugriff (PDF)

ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1775

2023

Volltextzugriff (PDF)

Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13398

2021

Volltextzugriff (PDF)

Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease

Biomolecules (Basel, Switzerland), 2020-11, Vol.10 (11), p.1519

2020

Volltextzugriff (PDF)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease

Molecular neurodegeneration, 2016-01, Vol.11 (7), p.7-7, Article 7

2016

Volltextzugriff (PDF)

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro

Neurobiology of disease, 2014-03, Vol.63, p.1-11

2014

Volltextzugriff (PDF)

Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson's Disease

Nutrients, 2023-12, Vol.16 (1), p.85

2023

Volltextzugriff (PDF)

Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils

Neurobiology of disease, 2015-02, Vol.74, p.89-101

2015

Volltextzugriff (PDF)

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology

Neurobiology of disease, 2015-07, Vol.79, p.81-99

2015

Volltextzugriff (PDF)

Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity

Frontiers in neuroscience, 2018-02, Vol.12, p.81-81

2018

Volltextzugriff (PDF)

Higher O-GlcNAc Levels Are Associated with Defects in Progenitor Proliferation and Premature Neuronal Differentiation during in-Vitro Human Embryonic Cortical Neurogenesis

Frontiers in cellular neuroscience, 2017-12, Vol.11, p.415-415

2017

Volltextzugriff (PDF)

Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro

Neurochemistry international, 2019-09, Vol.128, p.115-126

2019

Volltextzugriff (PDF)

Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts

BMC complementary medicine and therapies, 2020-03, Vol.20 (1), p.73-21, Article 73

2020

Volltextzugriff (PDF)

Effects of Aminoglycoside Antibiotics on Human Embryonic Stem Cell Viability during Differentiation In Vitro

Stem Cells International, 2017-01, Vol.2017, p.2451927-18

2017

Volltextzugriff (PDF)

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

The Journal of biological chemistry, 2012-05, Vol.287 (19), p.15345-15364

2012

Volltextzugriff (PDF)

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity

Proceedings of the National Academy of Sciences - PNAS, 2022-04, Vol.119 (15), p.e2109617119

2022

Volltextzugriff (PDF)

Saturated fatty acid regulated lncRNA dataset during in vitro human embryonic neurogenesis

Data in brief, 2018-12, Vol.21, p.1061-1065

2018

Volltextzugriff (PDF)

Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders

Molecular therapy, 2024-06, Vol.32 (6), p.2034-2034

2024

Volltextzugriff (PDF)

Retraction Notice to: Corrigendum to “Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders”

Molecular therapy, 2024-06, Vol.32 (6), p.2035-2035

2024

Volltextzugriff (PDF)

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

Movement disorders, 2011-07, Vol.26 (8), p.1428-1435

2011

Volltextzugriff (PDF)

Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders

Molecular therapy, 2016-04, Vol.24 (4), p.746-758

2016

Volltextzugriff (PDF)

Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity

Frontiers in aging neuroscience, 2014-08, Vol.6, p.197

2014

Volltextzugriff (PDF)

A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein

Molecular neurodegeneration, 2016-08, Vol.11 (1), p.61-61, Article 61

2016

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Parkin Precipitates on Mitochondria via Aggregation and Autoubiquitination

History of Parkinson's Disease-Associated Gene, Parkin : Research over a Quarter Century in Quest of Finding the Physiological Substrate

Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice

ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein

Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy

Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro

Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson's Disease

Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology

Silencing of Glucocerebrosidase Gene in Drosophila Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity

Higher O-GlcNAc Levels Are Associated with Defects in Progenitor Proliferation and Premature Neuronal Differentiation during in-Vitro Human Embryonic Cortical Neurogenesis

Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro

Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts

Effects of Aminoglycoside Antibiotics on Human Embryonic Stem Cell Viability during Differentiation In Vitro

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity

Saturated fatty acid regulated lncRNA dataset during in vitro human embryonic neurogenesis

Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders

Retraction Notice to: Corrigendum to “Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders”

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders

Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity

A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein

Suchergebnisse filtern